DNTH
Dianthus Therapeutics, Inc. Common StockstockNASDAQ
Market OpenNov 19, 2026 9:51:54 AM EST
85.29USD+1.560%(+1.31)32,110
DNTH Financials
In Q3 FY 2026 (ended ), Dianthus Therapeutics, Inc. Common Stock (DNTH) reported revenue of $1.21M, net income of −$46.64M, operating cash flow of −$50.33M, and assets of $1.28B (filed ).
Loading financial statements…